Ann-sofie Johansson

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.

Journal: British journal of haematology

Published: February 04, 2026

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

Journal: Blood advances

Published: October 31, 2025

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Journal: Blood advances

Published: September 17, 2024

FOXO Dictates Initiation of B Cell Development and Myeloid Restriction in Common Lymphoid Progenitors.

FOXO Dictates Initiation of B Cell Development and Myeloid Restriction in Common Lymphoid Progenitors.

Journal: Frontiers in immunology

Published: February 21, 2022

Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years.

Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years.

Journal: EJHaem

Published: March 16, 2021

High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

Journal: Upsala journal of medical sciences

Published: November 26, 2020

Guided web-based treatment program for reducing cannabis use: a randomized controlled trial.

Guided web-based treatment program for reducing cannabis use: a randomized controlled trial.

Journal: Addiction science & clinical practice

Published: July 31, 2019

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.

Journal: British journal of haematology

Published: June 04, 2019

Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples.

Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples.

Journal: Haematologica

Published: January 20, 2019

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

Journal: Blood

Published: October 11, 2018

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 05, 2018

Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohorts.

Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohorts.

Journal: Scientific reports

Published: January 24, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026